shot-button
Home > Mumbai > Mumbai News > Article > Pharma cos must adapt existing vaccines as fast as possible

‘Pharma cos must adapt existing vaccines as fast as possible’

Premium

Updated on: 28 November,2021 07:58 AM IST  |  Mumbai
Vinod Kumar Menon | vinodm@mid-day.com

While its ability to paralyse T-cells, resist antibodies and evade the immune system makes Omicron a strain to reckon with, experts say more data is needed to know whether we will need a whole new vaccine to fight latest SARS CoV2 variant

‘Pharma cos must adapt existing vaccines as fast as possible’

Passengers wearing face shields and face masks are seen at Hong Kong International Airport. The Omicron variant has been identified in the country. Pic/Getty Images

The new Covid-19 variant, B.1.1.529 NU, has now officially been renamed Omicron (the 15th letter of Greek alphabet) by the WHO late Friday night. It’s the first new ‘variant of concern’ since Delta, which means the world needs to be on alert and healthcare service providers vigilant, as possible risk of reinfection is higher, according to health experts.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK